Thymic stromal lymphopoietin limits primary and recall CD8<sup>+</sup> T-cell anti-viral responses.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33439121.
- Also identified by DOI 10.7554/eLife.61912 and PMC identifier 7806261.
- Licence recorded as CC0.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Thymic stromal lymphopoietin (TSLP) is a cytokine that acts directly on CD4<sup>+</sup> T cells and dendritic cells to promote progression of asthma, atopic dermatitis, and allergic inflammation. However, a direct role for TSLP in CD8<sup>+</sup> T-cell primary responses remains controversial and its role in memory CD8<sup>+</sup> T cell responses to secondary viral infection is unknown. Here, we investigate the role of TSLP in both primary and recall responses in mice using two different viral systems. Interestingly, TSLP limited the primary CD8<sup>+</sup> T-cell response to influenza but did not affect T cell function nor significantly alter the number of memory CD8<sup>+</sup> T cells generated after influenza infection. However, TSLP inhibited memory CD8<sup>+</sup> T-cell responses to secondary viral infection with influenza or acute systemic LCMV infection. These data reveal a previously unappreciated role for TSLP on recall CD8<sup>+</sup> T-cell responses in response to viral infection, findings with potential translational implications.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Cytokines
- Lymphocytic choriomeningitis virus
- Orthomyxoviridae